Spots Global Cancer Trial Database for Study of CP-461 in Patients With Advanced Renal Cell Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Study of CP-461 in Patients With Advanced Renal Cell Cancer
Official Title: Phase II Study of CP-461 in Patients With Advanced Renal Cell Cancer
Study ID: NCT00036036
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the efficacy of CP-461 given twice-daily orally in locally advanced or metastatic renal cell cancer and to evaluate the safety profile of CP-461 in this patient population.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
UCLA Medical Center, Los Angeles, California, United States
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
